Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.
Comprehensive outcome research with safety data and practical protocol references
From collagen peptides to oral PTH tablets, the science of building stronger bones is entering an anabolic revolution.
The frontier of bone health is shifting from passive maintenance to active restoration. New oral PTH tablets, synergistic collagen stacks, and a regulatory fast-track for clinical trials are transforming how we approach skeletal resilience — but the fragility paradox reminds us that density alone is not enough.
Evidence-graded testosterone profiles by ester and formulation, with safety data and peptide alternatives
The most prescribed testosterone ester outside the US, with a 4.5-7 day half-life that demands weekly dosing for stable levels. What the clinical data says about the hepcidin hijack, erythrocytosis, and why dosing frequency matters more than dose size.
Evidence-graded profile of testosterone enanthate: the hepcidin mechanism behind erythrocytosis, DHT and the scrotal paradox, dosing frequency pharmacokinetics, the TRAVERSE prostate saturation model, age-stratified risk, and peptide alternatives.
35+
Articles
18
Categories